Reversatrol™ is an innovative antioxidant supplement engineered for healthy ageing, balanced inflammation, and overall wellness. It addresses the challenge of low bioavailability in resveratrol supplementation, caused by the compound’s rapid metabolism.
Reversatrol™ uses ResveraFen, a patented form of resveratrol, clinically proven to enhance bioavailability by over tenfold. This results in a sustained release and improved transport of the compound, making Reversatrol™ more effective than traditional supplements.
The formulation also incorporates Hybrid-FENUMAT™ technology, pairing resveratrol with an oil for increased solubility and prebiotic fenugreek seeds to further improve bioavailability.
Reversatrol™ is 100% natural, food-grade, and adheres to clean label standards. The single-dose design makes it an easy addition to your daily health regimen.
Resveratrol, a polyphenol found in grapes, is known for its antioxidant properties, protective against diseases like heart disease, inflammation, and cancer, and promotes longevity. Reversatrol™ uses ResveraFen and proprietary Hybrid-FENUMAT™ technology to enhance bioavailability more than 10 times, making this supplement a powerful tool for health and wellness.
Featured Benefits:
– Include preventing resveratrol degradation, higher bioavailability, lower daily dose, retention of nutritional value,
– preventing rejection of nutrients by the immune system.
– It achieves a tenfold increase in resveratrol absorption and bioavailability.
– Supporting healthy inflammation levels, cardiovascular benefits, and promoting global trends in longevity.
How to use:
– Adults 18 years and older: Take 1 to 2 capsules once daily on an empty stomach preferably 30 min to 1 hour before a meal.
Warning:
– Not suitable for children. Consult a relevant healthcare provider prior to use, especially if you are pregnant or breastfeeding,
– taking prescription medication (including anticoagulants and antiplatelet medicines), or if you have a hormone-sensitive condition.
– For more details, please see the Patient Information Leaflet.